A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.

A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.

Item
http://www.wikidata.org/entity/Q36977417
Extracellular Matrix, a Hard Player in AngiogenesisCombined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer.Effect and mechanism of thrombospondin-1 on the angiogenesis potential in human endothelial progenitor cells: an in vitro studyNew ways to successfully target tumor vasculature in ovarian cancer.Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.Dosing de novo combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers.The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.Placental growth factor in cancer.Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.Thrombospondins: A Role in Cardiovascular Disease.
P2860

A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.

Item
http://www.wikidata.org/entity/Q36977417
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.
@en
type
label
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.
@en
prefLabel
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932